Skip to main content
Top
Published in: Critical Care 1/2011

Open Access 01-02-2011 | Poster presentation

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients

Authors: M Ruhnke, J Paiva, W Meersseman, J Pachl, I Grigoras, G Sganga, F Menichetti, P Montravers, G Auzinger, G Dimopoulos, M Borges Sá, P Miller, T Marček, M Kantecki

Published in: Critical Care | Special Issue 1/2011

Login to get access

Excerpt

A recent study found anidulafungin (ANI) safe and effective for candidemia/invasive candidiasis (C/IC) in selected populations of ICU patients [1]. A post hoc analysis of this study was performed to evaluate the efficacy of ANI in the same populations, but in non-neutropenic C/IC patients only. …
Literature
1.
go back to reference Paiva JA, et al.: Anidulafungin (ANID) for treatment of candidemia/invasive candidiasis (C/IC) in selected intensive care unit (ICU) populations. Crit Care Med 2010,38(12 Suppl):297. Paiva JA, et al.: Anidulafungin (ANID) for treatment of candidemia/invasive candidiasis (C/IC) in selected intensive care unit (ICU) populations. Crit Care Med 2010,38(12 Suppl):297.
Metadata
Title
Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
Authors
M Ruhnke
J Paiva
W Meersseman
J Pachl
I Grigoras
G Sganga
F Menichetti
P Montravers
G Auzinger
G Dimopoulos
M Borges Sá
P Miller
T Marček
M Kantecki
Publication date
01-02-2011
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9660

Other articles of this Special Issue 1/2011

Critical Care 1/2011 Go to the issue